Skip to content
ClinCalc Pro
Menu
Topical antiseptic (biguanide)

Chlorhexidine (Burns / Wound Antiseptic)

Brand names: Hibiscrub, ChloraPrep, Unisept

Chlorhexidine is a topical antiseptic used for skin disinfection, wound cleansing, and bathing of burns patients to reduce microbial colonisation and cross-infection.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Its cationic biguanide structure binds negatively charged bacterial cell membranes, disrupting them and causing leakage of cell contents, giving broad activity against Gram-positive and Gram-negative organisms.

Prescribing in practice

  • Chlorhexidine can cause anaphylaxis, and the MHRA has warned of this risk with medical and antiseptic products, so a history of reaction must be sought and exposure avoided in sensitised patients.
  • It is for external use only and should be kept away from the eyes, middle ear, and meninges as it is neurotoxic and ototoxic to those tissues.
  • Contact dermatitis and local irritation can occur with repeated application to broken skin.

Monitoring

Monitor for hypersensitivity reactions and for local skin irritation with repeated use.

Counselling the patient

  • This wash or solution helps reduce germs on the skin and wounds.
  • Tell staff immediately about any rash, swelling, or breathing difficulty, and keep it away from the eyes.

Evidence & guidelines

Chlorhexidine is a standard antiseptic for skin and wound antisepsis; the MHRA has issued safety advice on the risk of anaphylactic reactions.

Reference: PHE MRSA Decolonisation Guidelines; NICE CG74 Surgical Site Infection; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.